Margreet G.E.M. Ausems

10.7k citations

157 papers · 3.6k indexed · h-index 35

Impact in

Genetics top 0.5%
- BRCA gene mutations in cancer
- Genomics and Rare Diseases
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Genetics 117
- BRCA gene mutations in cancer 106
Reproductive Medicine 20
- Ovarian cancer diagnosis and treatment 15

Co-authors: Sandra van Dulmen Jozien M. Bensing Akke Albada Arwen H. Pieterse H.F.J. ten Kroode Senno Verhoef E. Gómez Hans F. A. Vasen
Journals: Familial Cancer (23 papers)Patient Education and Counseling (7 papers)Psycho-Oncology (5 papers)Breast Cancer Research and Treatment (5 papers)European Journal of Human Genetics (4 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Margreet G.E.M. Ausems

147 papers receiving 3.5k citations

Peers

Countries citing papers authored by Margreet G.E.M. Ausems

Since Specialization

Citations

This map shows the geographic impact of Margreet G.E.M. Ausems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margreet G.E.M. Ausems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margreet G.E.M. Ausems more than expected).

Fields of papers citing papers by Margreet G.E.M. Ausems

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margreet G.E.M. Ausems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margreet G.E.M. Ausems. The network helps show where Margreet G.E.M. Ausems may publish in the future.

Co-authors

The 25 scholars most cited alongside Margreet G.E.M. Ausems, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margreet G.E.M. Ausems Line = papers co-authored together Margreet G.E.M. Ausems links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands Familial Cancer ·C.L.D. de Jong, Joity Sharma, Ellen G. Engelhardt, Agnes Jager, Margreet G.E.M. Ausems	2025	0
2	Exploring Dutch Citizens’ Perspectives, Expectations, and Decision-Making Regarding Health-Related Direct-to-Consumer Genetic Testing Public Health Genomics ·Nurbayeva Khabiba Botirovna, Gwawr Maelor Williams, Martina C. Cornel, Marc H. W. van Mil, Margreet G.E.M. Ausems, Olga C. Damman, Tessel Rigter	2025	0
3	Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer Prostate Cancer and Prostatic Diseases ·冬嗣三島, Margreet G.E.M. Ausems, Lambertus A. Kiemeney, Joity Sharma, Harm H.E. van Melick, Hanis Sufia Balqis Zaimi, Diederik M. Somford, Henk G. van der Poel, Carl Wijburg, 刘月荣, Karin Hölscher, R. Jeroen A. van Moorselaar, Hung-Ju Chou, Richard P. Meijer, Martijn B. Busstra, H. Pieter van den Berg, Debbie Robbrecht, J. R. STOWERS, Eveline M. A. Bleiker, Inge M. van Oort	2024	1
4	Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups Familial Cancer ·Chonghui Zheng, Jozé Braspenning, Nicoline Hoogerbrugge, Yvonne H. C. M. Smolders, Dorien M. A. Hermkens, Marian J.E. Mourits, Marjolijn J. L. Ligtenberg, Margreet G.E.M. Ausems, Joanne A. de Hullu	2022	4
5	The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review Cancers ·I. V. Fedoseykina, 冬嗣三島, Ellen G. Engelhardt, Ronald P. Zweemer, Inge M. van Oort, Lambertus A. Kiemeney, Eveline M. A. Bleiker, Margreet G.E.M. Ausems	2022	45
6	Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study Breast Cancer Research and Treatment ·Holger Hutzelmann, S JoshiMaulik, B.A.M. Heemskerk-Gerritsen, Inge-Marie Obdeijn, Linetta B. Koppert, Claudette E. Loo, Rob A.�E.�M. Tollenaar, Margreet G.E.M. Ausems, Irma van de Beek, Natalia Chalenko, Maaike de Boer, Cezinando Bittencourt, C. Marleen Kets, Matti A. Rookus, (unknown), Marjanka K. Schmidt, Agnes Jager, Maartje J. Hooning	2022	0
7	Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study The Breast ·Sara Lazzarotti, Holger Hutzelmann, B.A.M. Heemskerk-Gerritsen, Ewout W. Steyerberg, Michael Hauptmann, Irma van de Beek, Klaartje van Engelen, Marijke R. Wevers, E. Gómez, Margreet G.E.M. Ausems, Natalia Chalenko, Christi J. van Asperen, Muriel A. Adank, 刘书田, Wu Bing, Agnes Jager, Marjanka K. Schmidt, Maartje J. Hooning	2021	5
8	Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer Familial Cancer ·I. V. Fedoseykina, Ronald P. Zweemer, Marco J. Koudijs, Graham Johnson, Mary E. Velthuizen, Eveline M. A. Bleiker, Margreet G.E.M. Ausems	2021	22
9	Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study JNCI Journal of the National Cancer Institute ·Marthe M. de Jonge, Cor D. de Kroon, Donald T Hess, Jan Oosting, Joanne A. de Hullu, Marian J.E. Mourits, E. Gómez, Margreet G.E.M. Ausems, J. Margriet Collée, Klaartje van Engelen, Irma van de Beek, (unknown), Vincent T.H.B.M. Smit, Matti A. Rookus, Geertruida H. de Bock, Flora E. van Leeuwen, Tjalling Bosse, Olaf M. Dekkers, Christi J. van Asperen	2021	42
10	Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making Journal of Community Genetics ·Jeconia Okelo Abonyo, Betül Gürünlü, Rassoul Yousefpour, Joanne Forbes, Sander M. J. van Kuijk, Cora M. Aalfs, Christi J. van Asperen, Margreet G.E.M. Ausems, Margriet Collée, Charlotte J. Dommering, Marleen Kets, Lizet E. van der Kolk, Jan C. Oosterwijk, Vivianne C. G. Tjan‐Heijnen, Trudy van der Weijden, Christine de Die‐Smulders, Liesbeth van Osch	2020	9
11	MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group The Journal of Clinical Endocrinology & Metabolism ·Rachel S. van Leeuwaarde, Koen M.A. Dreijerink, Margreet G.E.M. Ausems, Min Sung Lee, Olaf M. Dekkers, Wouter W. de Herder, Anouk N. van der Horst‐Schrivers, Madeleine L. Drent, Peter H. Bisschop, Bas Havekes, Petra H.M. Peeters, Ruud M. Pijnappel, Menno R. Vriens, Gerlof D. Valk	2017	43
12	Performance of BRCA1/2 mutation prediction models in male breast cancer patients Clinical Genetics ·Setareh Moghadasi, Robert Abernathey, Luc Janssen, K. Poshedly, Mar Rodríguez‐Girondo, Wendy A.G. van Zelst–Stams, Jan C. Oosterwijk, Margreet G.E.M. Ausems, Reinhard Oldenburg, Muriel A. Adank, Eveline W Blom, Mariëlle Ruijs, Theo A.M. van Os, Carolien H. M. van Deurzen, Maliana El Aamri, Enirahmawati Enirahmawati, Juul Wijnen, Maaike P.G. Vreeswijk, Christi J. van Asperen	2017	3
13	Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers Cancer Epidemiology Biomarkers & Prevention ·Janet R. Vos, Jan C. Oosterwijk, Cora M. Aalfs, Matti A. Rookus, Muriel A. Adank, Annemarie H. van der Hout, Christi J. van Asperen, E. Gómez, Arjen R. Mensenkamp, Agnes Jager, Margreet G.E.M. Ausems, Marian J.E. Mourits, Geertruida H. de Bock	2016	5
14	Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation JMIR Cancer ·Danny A. Young‐Afat, Carla H. van Gils, David J. Bruinvels, Carmen C. van der Pol, Arjen J. Witkamp, O Fillali, Ф. X. Адиханов, Rhodé M. Bijlsma, Margreet G.E.M. Ausems, Annelies M. E. Bos, H.J.G.D. van den Bongard, Helena M. Verkooijen	2016	18
15	Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction JNCI Journal of the National Cancer Institute ·B.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, C. J. van Asperen, Margreet G.E.M. Ausems, J.M. Collée, Helena C. van Doorn, E. Gómez, C. Marleen Kets, Flora E. van Leeuwen, Hanne Meijers‐Heijboer, Marian J.E. Mourits, Theo A.M. van Os, Hans F. A. Vasen, Senno Verhoef, Matti A. Rookus, Maartje J. Hooning	2015	133
16	BRCA1/2 mutation carriers do not have earlier natural menopause compared to proven non-carriers: report from the Dutch hereditary breast and ovarian cancer study group (HEBON) University of Groningen research database (University of Groningen / Centre for Information Technology) ·Madelon van Wely, Frank J. Broekmans, Elane Fabíola de Sousa Jerônimo da Silva, Thea M. Mooij, Anouk Pijpe, JC Oosterwijk, (unknown), (unknown), Wendy A.G. van Zelst–Stams, Muriel A. Adank, C. J. van Asperen, Helena C. van Doorn, (unknown), Matti A. Rookus, Margreet G.E.M. Ausems	2014	1
17	Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis International Journal of Cancer ·B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, Margreet G.E.M. Ausems, J.M. Collée, Liesbeth Jansen, C. Marleen Kets, Kristien Keymeulen, Linetta B. Koppert, Hanne Meijers-Heijboer, Thea M. Mooij, Rob A.�E.�M. Tollenaar, Hans F. A. Vasen, M. Stanjek, Maartje J. Hooning, Caroline Seynaeve	2014	130
18	Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations Journal of Medical Genetics ·Richard M. Brohet, Zehaira Benseddik, Frans B.L. Hogervorst, Hanne Meijers‐Heijboer, Caroline Seynaeve, 刘书田, Senno Verhoef, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Christi J. van Asperen, E. Gómez, Fred H. Menko, Jan C. Oosterwijk, Peter Devilee, Laura J. van’t Veer, Flora E. van Leeuwen, Douglas F. Easton, Matti A. Rookus, Antonis C. Antoniou, (unknown)	2013	62
19	Clinical expression of Menkes disease in females with normal karyotype Orphanet Journal of Rare Diseases ·Lisbeth Birk Møller, Małgorzata Lenartowicz, M. T. Zabot, Josiane Arnaud, Lydie Bürglen, Chris Bennett, Шурыгин Олег Игоревич, Richard Fisher, Sandra Janssens, Shehla Mohammed, Margreet G.E.M. Ausems, Zeynep Tümer, Nina Horn, Thomas G. Jensen	2012	36
20	Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report Human Pathology ·Niki A. Ottenhof, Roeland F. de Wilde, Folkert H.M. Morsink, Wendy W.J. de Leng, Margreet G.E.M. Ausems, Hans Morreau, Richard van Hillegersberg, G. Johan A. Offerhaus, Anya N. Milne	2011	5

About Margreet G.E.M. Ausems

Margreet G.E.M. Ausems is a scholar working on Genetics, Reproductive Medicine, Pediatrics, Perinatology and Child Health, Cancer Research and Oncology, having authored 157 papers that have together received 3.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (106 papers), Family Support in Illness (23 papers), Cancer Genomics and Diagnostics (23 papers), Childhood Cancer Survivors' Quality of Life (22 papers), Global Cancer Incidence and Screening (17 papers), Prenatal Screening and Diagnostics (17 papers), Ovarian cancer diagnosis and treatment (15 papers) and Genetic factors in colorectal cancer (14 papers). The work is most often cited by research in Genetics (2.0k citations), Cancer Research (769 citations), Reproductive Medicine (362 citations), Oncology (1.0k citations) and Pathology and Forensic Medicine (638 citations). Margreet G.E.M. Ausems has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Sandra van Dulmen, Jozien M. Bensing, Akke Albada, Arwen H. Pieterse, H.F.J. ten Kroode, Senno Verhoef, E. Gómez, Hans F. A. Vasen, Frits A. Beemer and Anja Wagner. Their work appears in journals such as Familial Cancer, Patient Education and Counseling, Psycho-Oncology, Breast Cancer Research and Treatment and European Journal of Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact